Nathan Hardy SEC EDGAR Filings (CIK 0001830053)

SEC EDGAR filings, ownership reports, and insider transactions for Nathan Hardy.

Business address
C/O Sana Biotechnology, Inc., 188 East Blaine Street, Suite 400, Seattle, WA, 98102
Top holdings (ownership)
SANA
⭐ Add to watchlist ⭐
Get insider transactions for this reporting owner
Nathan Hardy has filed 8 SEC EDGAR filings since 03 Feb 2021

Latest Filings

Recent SEC filings for Nathan Hardy including 144, 4, 3.

Form type Document Filing Description Filing date Reporting date File number(s)
144 Open 144 document View SEC filing for 144 26 Nov 2024
144 Open 144 document View SEC filing for 144 25 Nov 2024
144 Open 144 document View SEC filing for 144 21 Oct 2024
4 Open 4 document View SEC filing for 4 PRIMARY DOCUMENT 08 Mar 2024 07 Mar 2024 001-39941
4 Open 4 document View SEC filing for 4 PRIMARY DOCUMENT 03 Nov 2023 02 Nov 2023 001-39941
4 Open 4 document View SEC filing for 4 PRIMARY DOCUMENT 03 Mar 2023 02 Mar 2023 001-39941
4 Open 4 document View SEC filing for 4 PRIMARY DOCUMENT 08 Mar 2022 03 Mar 2022 001-39941
3 Open 3 document View SEC filing for 3 FORM 3 SUBMISSION 03 Feb 2021 03 Feb 2021 001-39941

About this filer

Nathan Hardy files with the SEC under CIK 0001830053. This page aggregates EDGAR filings and related ownership activity.

See reporting owner transactions.

FAQ

What is a CIK?
A Central Index Key (CIK) is a unique identifier assigned by the SEC to each filer.
Why are some filings missing?
New filings appear as the SEC updates EDGAR, and older records can vary by availability.
How often is this page updated?
Updates follow new EDGAR submissions and periodic data refreshes.

Related pages